Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-07-16 EDT 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Revisions Context Therapeutics Inc.